Current Neuropharmacology

Current Neuropharmacology

CURR NEUROPHARMACOL
影响因子:5.3
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Bentham Science Publishers B.V.
发刊时间:2003
发刊频率:Quarterly
收录数据库:SCIE/Scopus收录
ISSN:1570-159X

期刊介绍

Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
当前神经药理学旨在提供当前,全面/迷你审查和客座编辑的问题,所有领域的神经药理学和相关事项的神经科学。综述涵盖了神经药理学和神经科学的分子、细胞和系统/行为方面的领域。该杂志为神经药理学家和神经科学家提供了一个全面的、多学科的专家论坛。
年发文量 164
国人发稿量 48.48
国人发文占比 0.3%
自引率 -
平均录取率0
平均审稿周期 >12周,或约稿
版面费 -
偏重研究方向 医学-神经科学
期刊官网 http://benthamscience.com/journal/index.php?journalID=cn
投稿链接 http://bsp-cms.eurekaselect.com/index.php/CN

期刊高被引文献

Ayahuasca: Psychological and Physiologic Effects, Pharmacology and \u2028Potential Uses in Addiction and Mental Illness
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180125095902
Neuroprotective Strategies for Neurological Disorders by Natural \u2028Products: An update
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180911124605
Neuro-toxic and Reproductive Effects of BPA
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190726112101
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180917105033
Synaptic Elimination in Neurological Disorders
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190603170511
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180508113025
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666181127125704
Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180302115032
Statins and the Brain: More than Lipid Lowering Agents?
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X15666170703101816
Role of Estradiol in the Expression of Genes Involved in Serotonin Neurotransmission: Implications for Female Depression
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180628165107
Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180419124508
Antioxidant Properties of Crocus Sativus L. and Its Constituents and \u2028Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and \u2028Parkinson’s Disease
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180321095705
Drug Treatment of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia)
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190320164223
Relevance of CYP2C9 Function in Valproate Therapy
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X15666171109143654
Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180905094123
Insights into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180419123022
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180302120322
Potential Metabolic and Behavioural Roles of the Putative Endo-\u2028cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190118143014
Therapeutic Potential of Multifunctional Tacrine Analogues
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180412091908
Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190811161807
Highlighting the Role of Cognitive and Brain Reserve in the Substance use Disorder Field
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190617100707
The Delicate Equilibrium between Oxidants and Antioxidants in Brain Glioma
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X16666180302120925
New Psychoactive Substances: A Matter of Time
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X1709190729101751
Role of Descending Dopaminergic Pathways in Pain Modulation
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190430102531
Targeting Cytokines for Morphine Tolerance: A Narrative Review
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X15666171128144441
Nimodipine Reappraised: An Old Drug with a Future
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190927113021
Traumatic Brain Injury: A Forensic Approach: A Literature Review
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191101123145
An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191001142934
The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191001141849
The Era of Cerebellar Therapy.
来源期刊:Current neuropharmacologyDOI:10.2174/1570159X1701181129111212
Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases
来源期刊:Current NeuropharmacologyDOI:10.2174/1385272823666191021124443
Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X15666170915160707
The Forgotten Cells: Role of Astrocytes in Mood Disorders During the Aging
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X1705190405151808
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X15666171109125643
Far-3infrared Ray-mediated Antioxidant Potentials are Important for \u2028Attenuating Psychotoxic Disorders
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190228114318
The Endocannabinoid System May Modulate Sleep Disorders in Aging
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190801155922
Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191101125530
Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191127112339
Meet Our Editorial Board Member
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X1710190911121934
Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190726115623
Recent Advances in Epilepsy
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X1710190911122554
Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.
来源期刊:Current neuropharmacologyDOI:10.2174/1570159X1708190709144820
Amphetamine Use in the Elderly: A Systematic Review of the Literature
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191010093021
Meet Our Editorial Board Member
来源期刊:Current NeuropharmacologyDOI:10.2174/187152061612161104160937
Using Cell Cultures for the Investigation of Treatments for Attention \u2028Deficit Hyperactivity Disorder: A Systematic Review
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666190409143155
The Kinetic Component in Drug Discovery: Using the Most Basic Pharmacological Concepts to Advance in Selecting Drugs to Combat CNS Diseases
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191001144309
Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191001145550
Trigeminal Neuralgia: Basic and Clinical Aspects
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191010094350
A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
来源期刊:Current NeuropharmacologyDOI:10.2174/1570159X17666191010103044
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer s Disease.
来源期刊:Current neuropharmacologyDOI:10.2174/1570159X16666180702144644

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
29.27%3.39%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
NEUROSCIENCES
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
2区
NEUROSCIENCES 神经科学
3区
2023年12月升级版
医学2区
PHARMACOLOGY & PHARMACY 药学
2区
NEUROSCIENCES 神经科学
3区
2022年12月旧的升级版
医学2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
2区